Search Results - "Logeart‐Avramoglou, D."

Refine Results
  1. 1

    Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long‐term, severe and continuous hypoxia by Deschepper, M., Oudina, K., David, B., Myrtil, V., Collet, C., Bensidhoum, M., LogeartAvramoglou, D., Petite, H.

    Published in Journal of cellular and molecular medicine (01-07-2011)
    “…Use of mesenchymal stem cells (MSCs) has emerged as a potential new treatment for various diseases but has generated marginally successful results. A…”
    Get full text
    Journal Article
  2. 2

    Engineering bone: challenges and obstacles by LogeartAvramoglou, D., Anagnostou, F., Bizios, R., Petite, H.

    Published in Journal of cellular and molecular medicine (01-01-2005)
    “…Repair of large bone defects is still a challenge for the orthopaedic, reconstructive and maxillo‐facial surgeon. Availability of pluripotent stem cells from…”
    Get full text
    Journal Article
  3. 3

    Human mesenchymal stem cell responses to hydrostatic pressure and shear stress by Becquart, P, Cruel, M, Hoc, T, Sudre, L, Pernelle, K, Bizios, R, Logeart-Avramoglou, D, Petite, H, Bensidhoum, M

    Published in European cells & materials (19-02-2016)
    “…The effects of mechanical stimuli to which cells are exposed in vivo are, at best, incompletely understood; in this respect, gene-level information regarding…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Assessment of a polyelectrolyte multilayer film coating loaded with BMP-2 on titanium and PEEK implants in the rabbit femoral condyle by Guillot, R., Pignot-Paintrand, I., Lavaud, J., Decambron, A., Bourgeois, E., Josserand, V., Logeart-Avramoglou, D., Viguier, E., Picart, C.

    Published in Acta biomaterialia (01-05-2016)
    “…[Display omitted] The aim of this study was to evaluate the osseointegration of titanium implants (Ti-6Al-4V, noted here TA6V) and poly(etheretherketone) PEEK…”
    Get full text
    Journal Article
  6. 6

    Strategies for improving the efficacy of bioengineered bone constructs: a perspective by Petite, H., Vandamme, K., Monfoulet, L., Logeart-Avramoglou, D.

    Published in Osteoporosis international (01-06-2011)
    “…Bioengineered bone scaffolds are intended for use in large bone defects. Successful bone constructs should stimulate and support both the onset and the…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Optimization of a gene electrotransfer method for mesenchymal stem cell transfection by Ferreira, E, Potier, E, Logeart-Avramoglou, D, Salomskaite-Davalgiene, S, Mir, L M, Petite, H

    Published in Gene therapy (01-04-2008)
    “…Gene electrotransfer is an efficient and reproducible nonviral gene transfer technique useful for the nonpermanent expression of therapeutic transgenes. The…”
    Get full text
    Journal Article
  8. 8

    A comparative study of tissue-engineered constructs from Acropora and Porites coral in a large animal bone defect model by Decambron, A, Manassero, M, Bensidhoum, M, Lecuelle, B, Logeart-Avramoglou, D, Petite, H, Viateau, V

    Published in Bone & joint research (01-04-2017)
    “…To compare the therapeutic potential of tissue-engineered constructs (TECs) combining mesenchymal stem cells (MSCs) and coral granules from either or to repair…”
    Get full text
    Journal Article
  9. 9

    An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct by Logeart-Avramoglou, D., Bourguignon, M., Oudina, K., Ten Dijke, P., Petite, H.

    Published in Analytical biochemistry (01-02-2006)
    “…Bone morphogenetic proteins (BMPs) control cell fate by regulating gene expression, especially inhibitor of differentiation (Id) genes. This property has been…”
    Get full text
    Journal Article
  10. 10

    Sustained and promoter dependent bone morphogenetic protein expression by rat mesenchymal stem cells after BMP-2 transgene electrotransfer by Ferreira, E, Potier, E, Vaudin, P, Oudina, K, Bensidhoum, M, Logeart-Avramoglou, D, Mir, L M, Petite, H

    Published in European cells & materials (09-07-2012)
    “…Transplantation of mesenchymal stem cells (MSCs) with electrotransferred bone morphogenetic protein-2 (BMP-2) transgene is an attractive therapeutic modality…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating by Crouzier, Thomas, Sailhan, Frédéric, Becquart, Pierre, Guillot, Raphael, Logeart-Avramoglou, Delphine, Picart, Catherine

    Published in Biomaterials (01-10-2011)
    “…Abstract Delivering rhBMP-2 (recombinant Bone Morphogenic Protein-2) at low but therapeutically efficient dose is one of the current challenges for bone tissue…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The stability of BMP loaded polyelectrolyte multilayer coatings on titanium by Guillot, Raphael, Gilde, Flora, Becquart, Pierre, Sailhan, Frédéric, Lapeyrere, Aurélien, Logeart-Avramoglou, Delphine, Picart, Catherine

    Published in Biomaterials (01-07-2013)
    “…Abstract Immobilization of bone morphogenetic proteins (BMP) onto material surfaces is a promising, but still challenging, strategy for achieving dependable…”
    Get full text
    Journal Article
  17. 17

    Quiescence Preconditioned Human Multipotent Stromal Cells Adopt a Metabolic Profile Favorable for Enhanced Survival under Ischemia by Moya, Adrien, Larochette, Nathanaël, Paquet, Joseph, Deschepper, Mickael, Bensidhoum, Morad, Izzo, Valentina, Kroemer, Guido, Petite, Hervé, Logeart‐Avramoglou, Delphine

    Published in Stem cells (Dayton, Ohio) (01-01-2017)
    “…A major impediment to the development of therapies with mesenchymal stem cells/multipotent stromal cells (MSC) is the poor survival and engraftment of MSCs at…”
    Get full text
    Journal Article
  18. 18

    Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression by Potier, Esther, Ferreira, Elisabeth, Andriamanalijaona, Rina, Pujol, Jean-Pierre, Oudina, Karim, Logeart-Avramoglou, Delphine, Petite, Hervé

    Published in Bone (New York, N.Y.) (01-04-2007)
    “…Abstract Mesenchymal stromal cells (MSCs) seeded onto biocompatible scaffolds have been proposed for repairing bone defects. When transplanted in vivo , MSCs…”
    Get full text
    Journal Article
  19. 19

    Optimisation des matériaux hybrides à base de cellules souches pour la réparation de grands défauts osseux by Monfoulet, L, Deschepper, M, Vandamme, K, Manassero, M, Becquart, P, Bensidhoum, M, Petite, H, Pacard, E, Viateau, V, Logeart-Avramoglou, D

    Published in Ingénierie et recherche biomédicale (01-04-2012)
    “…Résumé Les limites imposées par l’autogreffe osseuse ont poussé au développement de nouvelles stratégies pour le traitement des grandes pertes de substances…”
    Get full text
    Journal Article
  20. 20

    Ischemia is the prime but not the only cause of human multipotent stromal cell death in tissue-engineered constructs in vivo by Becquart, Pierre, Cambon-Binder, Adeline, Monfoulet, Laurent-Emmanuel, Bourguignon, Marianne, Vandamme, Katleen, Bensidhoum, Morad, Petite, Hervé, Logeart-Avramoglou, Delphine

    Published in Tissue engineering. Part A (01-10-2012)
    “…Local tissue ischemia is a prime cause responsible for the massive cell death in tissue-engineered (TE) constructs observed postimplantation. To assess the…”
    Get more information
    Journal Article